nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC6—prostate gland—prostate cancer	0.0103	0.053	CbGeAlD
Vorinostat—HDAC8—prostate gland—prostate cancer	0.00917	0.047	CbGeAlD
Vorinostat—HDAC4—prostate gland—prostate cancer	0.00891	0.0457	CbGeAlD
Vorinostat—Azelaic Acid—SRD5A2—prostate cancer	0.0088	1	CrCbGaD
Vorinostat—HDAC11—prostate gland—prostate cancer	0.008	0.041	CbGeAlD
Vorinostat—NCOR1—prostate gland—prostate cancer	0.00776	0.0398	CbGeAlD
Vorinostat—HDAC3—prostate gland—prostate cancer	0.0068	0.0349	CbGeAlD
Vorinostat—HDAC8—renal system—prostate cancer	0.00625	0.0321	CbGeAlD
Vorinostat—HDAC1—prostate gland—prostate cancer	0.00623	0.032	CbGeAlD
Vorinostat—HDAC9—prostate gland—prostate cancer	0.00613	0.0314	CbGeAlD
Vorinostat—HDAC3—seminal vesicle—prostate cancer	0.00575	0.0295	CbGeAlD
Vorinostat—HDAC11—renal system—prostate cancer	0.00545	0.028	CbGeAlD
Vorinostat—NCOR1—renal system—prostate cancer	0.00529	0.0271	CbGeAlD
Vorinostat—HDAC1—seminal vesicle—prostate cancer	0.00527	0.027	CbGeAlD
Vorinostat—HDAC8—bone marrow—prostate cancer	0.00473	0.0242	CbGeAlD
Vorinostat—HDAC4—bone marrow—prostate cancer	0.00459	0.0236	CbGeAlD
Vorinostat—HDAC1—epithelium—prostate cancer	0.00458	0.0235	CbGeAlD
Vorinostat—HDAC6—testis—prostate cancer	0.00455	0.0234	CbGeAlD
Vorinostat—HDAC3—urethra—prostate cancer	0.00455	0.0234	CbGeAlD
Vorinostat—HDAC1—renal system—prostate cancer	0.00425	0.0218	CbGeAlD
Vorinostat—HDAC1—urethra—prostate cancer	0.00417	0.0214	CbGeAlD
Vorinostat—HDAC8—testis—prostate cancer	0.00404	0.0207	CbGeAlD
Vorinostat—NCOR1—bone marrow—prostate cancer	0.004	0.0205	CbGeAlD
Vorinostat—HDAC4—testis—prostate cancer	0.00393	0.0201	CbGeAlD
Vorinostat—HDAC11—testis—prostate cancer	0.00352	0.0181	CbGeAlD
Vorinostat—HDAC3—bone marrow—prostate cancer	0.0035	0.018	CbGeAlD
Vorinostat—NCOR1—testis—prostate cancer	0.00342	0.0175	CbGeAlD
Vorinostat—HDAC6—lymph node—prostate cancer	0.0033	0.0169	CbGeAlD
Vorinostat—HDAC1—bone marrow—prostate cancer	0.00321	0.0165	CbGeAlD
Vorinostat—NR0B1—testis—prostate cancer	0.00321	0.0165	CbGeAlD
Vorinostat—HDAC9—bone marrow—prostate cancer	0.00316	0.0162	CbGeAlD
Vorinostat—HDAC2—prostate gland—prostate cancer	0.00313	0.0161	CbGeAlD
Vorinostat—HDAC3—testis—prostate cancer	0.003	0.0154	CbGeAlD
Vorinostat—HDAC8—lymph node—prostate cancer	0.00293	0.015	CbGeAlD
Vorinostat—HDAC4—lymph node—prostate cancer	0.00285	0.0146	CbGeAlD
Vorinostat—HDAC2—Teniposide—Etoposide—prostate cancer	0.00277	0.738	CbGdCrCtD
Vorinostat—HDAC1—testis—prostate cancer	0.00274	0.0141	CbGeAlD
Vorinostat—HDAC9—testis—prostate cancer	0.0027	0.0138	CbGeAlD
Vorinostat—HDAC11—lymph node—prostate cancer	0.00255	0.0131	CbGeAlD
Vorinostat—NCOR1—lymph node—prostate cancer	0.00248	0.0127	CbGeAlD
Vorinostat—HDAC2—epithelium—prostate cancer	0.0023	0.0118	CbGeAlD
Vorinostat—HDAC3—lymph node—prostate cancer	0.00217	0.0111	CbGeAlD
Vorinostat—HDAC2—renal system—prostate cancer	0.00213	0.011	CbGeAlD
Vorinostat—HDAC1—lymph node—prostate cancer	0.00199	0.0102	CbGeAlD
Vorinostat—HDAC9—lymph node—prostate cancer	0.00196	0.01	CbGeAlD
Vorinostat—HDAC2—bone marrow—prostate cancer	0.00161	0.00828	CbGeAlD
Vorinostat—HDAC2—testis—prostate cancer	0.00138	0.00708	CbGeAlD
Vorinostat—HDAC2—lymph node—prostate cancer	0.001	0.00513	CbGeAlD
Vorinostat—HDAC2—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000985	0.262	CbGdCrCtD
Vorinostat—Neutropenia—Docetaxel—prostate cancer	0.000294	0.000853	CcSEcCtD
Vorinostat—Sepsis—Epirubicin—prostate cancer	0.000293	0.000851	CcSEcCtD
Vorinostat—Anaemia—Mitoxantrone—prostate cancer	0.000293	0.00085	CcSEcCtD
Vorinostat—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000291	0.000844	CcSEcCtD
Vorinostat—Chest pain—Estradiol—prostate cancer	0.00029	0.00084	CcSEcCtD
Vorinostat—Pancytopenia—Capecitabine—prostate cancer	0.000289	0.000839	CcSEcCtD
Vorinostat—Hypokalaemia—Prednisone—prostate cancer	0.000286	0.000828	CcSEcCtD
Vorinostat—Neutropenia—Capecitabine—prostate cancer	0.000285	0.000826	CcSEcCtD
Vorinostat—Weight decreased—Docetaxel—prostate cancer	0.000285	0.000825	CcSEcCtD
Vorinostat—Leukopenia—Mitoxantrone—prostate cancer	0.000284	0.000823	CcSEcCtD
Vorinostat—Dry mouth—Estradiol—prostate cancer	0.000283	0.000822	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000283	0.000821	CcSEcCtD
Vorinostat—Dizziness—Ethinyl Estradiol—prostate cancer	0.000281	0.000816	CcSEcCtD
Vorinostat—Body temperature increased—Goserelin—prostate cancer	0.000277	0.000803	CcSEcCtD
Vorinostat—Cough—Mitoxantrone—prostate cancer	0.000277	0.000802	CcSEcCtD
Vorinostat—Acute coronary syndrome—Docetaxel—prostate cancer	0.000276	0.000802	CcSEcCtD
Vorinostat—Infection—Estradiol—prostate cancer	0.000276	0.0008	CcSEcCtD
Vorinostat—Weight decreased—Capecitabine—prostate cancer	0.000275	0.000799	CcSEcCtD
Vorinostat—Myocardial infarction—Docetaxel—prostate cancer	0.000275	0.000797	CcSEcCtD
Vorinostat—Hyperglycaemia—Capecitabine—prostate cancer	0.000275	0.000797	CcSEcCtD
Vorinostat—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000274	0.000795	CcSEcCtD
Vorinostat—Shock—Estradiol—prostate cancer	0.000273	0.000792	CcSEcCtD
Vorinostat—Chills—Etoposide—prostate cancer	0.000272	0.000788	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—prostate cancer	0.000271	0.000787	CcSEcCtD
Vorinostat—Vomiting—Ethinyl Estradiol—prostate cancer	0.000271	0.000785	CcSEcCtD
Vorinostat—Chest pain—Mitoxantrone—prostate cancer	0.00027	0.000783	CcSEcCtD
Vorinostat—Alopecia—Etoposide—prostate cancer	0.000268	0.000776	CcSEcCtD
Vorinostat—Acute coronary syndrome—Capecitabine—prostate cancer	0.000268	0.000776	CcSEcCtD
Vorinostat—Headache—Ethinyl Estradiol—prostate cancer	0.000267	0.000773	CcSEcCtD
Vorinostat—Myocardial infarction—Capecitabine—prostate cancer	0.000266	0.000772	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—prostate cancer	0.00026	0.000754	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—prostate cancer	0.000258	0.000749	CcSEcCtD
Vorinostat—Infection—Mitoxantrone—prostate cancer	0.000257	0.000745	CcSEcCtD
Vorinostat—Shock—Mitoxantrone—prostate cancer	0.000255	0.000738	CcSEcCtD
Vorinostat—Neutropenia—Prednisone—prostate cancer	0.000254	0.000736	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—prostate cancer	0.000254	0.000735	CcSEcCtD
Vorinostat—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000253	0.000735	CcSEcCtD
Vorinostat—Nausea—Ethinyl Estradiol—prostate cancer	0.000253	0.000733	CcSEcCtD
Vorinostat—Asthenia—Goserelin—prostate cancer	0.000251	0.000729	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—prostate cancer	0.00025	0.000726	CcSEcCtD
Vorinostat—Asthenia—Conjugated Estrogens—prostate cancer	0.000249	0.000722	CcSEcCtD
Vorinostat—Oedema peripheral—Docetaxel—prostate cancer	0.000248	0.000719	CcSEcCtD
Vorinostat—Pruritus—Goserelin—prostate cancer	0.000248	0.000719	CcSEcCtD
Vorinostat—Anorexia—Mitoxantrone—prostate cancer	0.000247	0.000715	CcSEcCtD
Vorinostat—Pruritus—Conjugated Estrogens—prostate cancer	0.000245	0.000712	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000245	0.000712	CcSEcCtD
Vorinostat—Weight decreased—Prednisone—prostate cancer	0.000245	0.000712	CcSEcCtD
Vorinostat—Hyperglycaemia—Prednisone—prostate cancer	0.000245	0.00071	CcSEcCtD
Vorinostat—Anaemia—Etoposide—prostate cancer	0.000244	0.000707	CcSEcCtD
Vorinostat—Decreased appetite—Estradiol—prostate cancer	0.000241	0.0007	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000241	0.000698	CcSEcCtD
Vorinostat—Oedema peripheral—Capecitabine—prostate cancer	0.00024	0.000696	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Estradiol—prostate cancer	0.00024	0.000695	CcSEcCtD
Vorinostat—Diarrhoea—Goserelin—prostate cancer	0.00024	0.000695	CcSEcCtD
Vorinostat—Fatigue—Estradiol—prostate cancer	0.000239	0.000694	CcSEcCtD
Vorinostat—Acute coronary syndrome—Prednisone—prostate cancer	0.000238	0.000691	CcSEcCtD
Vorinostat—Constipation—Estradiol—prostate cancer	0.000237	0.000689	CcSEcCtD
Vorinostat—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000237	0.000688	CcSEcCtD
Vorinostat—Myocardial infarction—Prednisone—prostate cancer	0.000237	0.000687	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—prostate cancer	0.000236	0.000684	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—prostate cancer	0.000232	0.000672	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—prostate cancer	0.000232	0.000672	CcSEcCtD
Vorinostat—Dizziness—Goserelin—prostate cancer	0.000232	0.000672	CcSEcCtD
Vorinostat—Cough—Etoposide—prostate cancer	0.00023	0.000667	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—prostate cancer	0.00023	0.000667	CcSEcCtD
Vorinostat—Dizziness—Conjugated Estrogens—prostate cancer	0.000229	0.000665	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—prostate cancer	0.000228	0.000662	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000227	0.000659	CcSEcCtD
Vorinostat—Chills—Docetaxel—prostate cancer	0.000226	0.000655	CcSEcCtD
Vorinostat—Decreased appetite—Mitoxantrone—prostate cancer	0.000225	0.000652	CcSEcCtD
Vorinostat—Chest pain—Etoposide—prostate cancer	0.000224	0.000651	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—prostate cancer	0.000223	0.000648	CcSEcCtD
Vorinostat—Fatigue—Mitoxantrone—prostate cancer	0.000223	0.000647	CcSEcCtD
Vorinostat—Vomiting—Goserelin—prostate cancer	0.000223	0.000646	CcSEcCtD
Vorinostat—Alopecia—Docetaxel—prostate cancer	0.000222	0.000645	CcSEcCtD
Vorinostat—Constipation—Mitoxantrone—prostate cancer	0.000221	0.000642	CcSEcCtD
Vorinostat—Vomiting—Conjugated Estrogens—prostate cancer	0.000221	0.00064	CcSEcCtD
Vorinostat—Body temperature increased—Estradiol—prostate cancer	0.00022	0.000637	CcSEcCtD
Vorinostat—Headache—Goserelin—prostate cancer	0.000219	0.000636	CcSEcCtD
Vorinostat—Chills—Capecitabine—prostate cancer	0.000219	0.000634	CcSEcCtD
Vorinostat—Headache—Conjugated Estrogens—prostate cancer	0.000217	0.00063	CcSEcCtD
Vorinostat—Alopecia—Capecitabine—prostate cancer	0.000215	0.000625	CcSEcCtD
Vorinostat—Dysgeusia—Docetaxel—prostate cancer	0.000215	0.000622	CcSEcCtD
Vorinostat—Infection—Etoposide—prostate cancer	0.000214	0.00062	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—prostate cancer	0.000213	0.000617	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—prostate cancer	0.000211	0.000612	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—prostate cancer	0.000211	0.000611	CcSEcCtD
Vorinostat—Muscle spasms—Docetaxel—prostate cancer	0.000211	0.000611	CcSEcCtD
Vorinostat—Nausea—Goserelin—prostate cancer	0.000208	0.000603	CcSEcCtD
Vorinostat—Dysgeusia—Capecitabine—prostate cancer	0.000208	0.000603	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—prostate cancer	0.000207	0.000599	CcSEcCtD
Vorinostat—Nausea—Conjugated Estrogens—prostate cancer	0.000206	0.000598	CcSEcCtD
Vorinostat—Anorexia—Etoposide—prostate cancer	0.000205	0.000595	CcSEcCtD
Vorinostat—Body temperature increased—Mitoxantrone—prostate cancer	0.000205	0.000593	CcSEcCtD
Vorinostat—Muscle spasms—Capecitabine—prostate cancer	0.000204	0.000592	CcSEcCtD
Vorinostat—Anaemia—Docetaxel—prostate cancer	0.000203	0.000587	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—prostate cancer	0.000201	0.000584	CcSEcCtD
Vorinostat—Asthenia—Estradiol—prostate cancer	0.000199	0.000578	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—prostate cancer	0.000198	0.000575	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000197	0.000572	CcSEcCtD
Vorinostat—Syncope—Docetaxel—prostate cancer	0.000197	0.00057	CcSEcCtD
Vorinostat—Pruritus—Estradiol—prostate cancer	0.000196	0.00057	CcSEcCtD
Vorinostat—Leukopenia—Docetaxel—prostate cancer	0.000196	0.000569	CcSEcCtD
Vorinostat—Anaemia—Capecitabine—prostate cancer	0.000196	0.000569	CcSEcCtD
Vorinostat—Loss of consciousness—Docetaxel—prostate cancer	0.000193	0.000559	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—prostate cancer	0.000192	0.000557	CcSEcCtD
Vorinostat—Alopecia—Prednisone—prostate cancer	0.000192	0.000556	CcSEcCtD
Vorinostat—Hyperglycaemia—Epirubicin—prostate cancer	0.000191	0.000555	CcSEcCtD
Vorinostat—Cough—Docetaxel—prostate cancer	0.000191	0.000555	CcSEcCtD
Vorinostat—Syncope—Capecitabine—prostate cancer	0.00019	0.000552	CcSEcCtD
Vorinostat—Diarrhoea—Estradiol—prostate cancer	0.00019	0.000551	CcSEcCtD
Vorinostat—Leukopenia—Capecitabine—prostate cancer	0.00019	0.000551	CcSEcCtD
Vorinostat—Decreased appetite—Etoposide—prostate cancer	0.000187	0.000543	CcSEcCtD
Vorinostat—Chest pain—Docetaxel—prostate cancer	0.000187	0.000541	CcSEcCtD
Vorinostat—Loss of consciousness—Capecitabine—prostate cancer	0.000186	0.000541	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—prostate cancer	0.000186	0.000541	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—prostate cancer	0.000186	0.000539	CcSEcCtD
Vorinostat—Asthenia—Mitoxantrone—prostate cancer	0.000186	0.000538	CcSEcCtD
Vorinostat—Fatigue—Etoposide—prostate cancer	0.000186	0.000538	CcSEcCtD
Vorinostat—Cough—Capecitabine—prostate cancer	0.000185	0.000537	CcSEcCtD
Vorinostat—Constipation—Etoposide—prostate cancer	0.000184	0.000534	CcSEcCtD
Vorinostat—Dizziness—Estradiol—prostate cancer	0.000184	0.000532	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—prostate cancer	0.000184	0.000532	CcSEcCtD
Vorinostat—Dry mouth—Docetaxel—prostate cancer	0.000182	0.000529	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000182	0.000529	CcSEcCtD
Vorinostat—Chest pain—Capecitabine—prostate cancer	0.000181	0.000524	CcSEcCtD
Vorinostat—Infection—Docetaxel—prostate cancer	0.000178	0.000515	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—prostate cancer	0.000178	0.000515	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—prostate cancer	0.000177	0.000513	CcSEcCtD
Vorinostat—Diarrhoea—Mitoxantrone—prostate cancer	0.000177	0.000513	CcSEcCtD
Vorinostat—Dry mouth—Capecitabine—prostate cancer	0.000177	0.000512	CcSEcCtD
Vorinostat—Vomiting—Estradiol—prostate cancer	0.000177	0.000512	CcSEcCtD
Vorinostat—Shock—Docetaxel—prostate cancer	0.000176	0.00051	CcSEcCtD
Vorinostat—Thrombocytopenia—Docetaxel—prostate cancer	0.000175	0.000508	CcSEcCtD
Vorinostat—Anaemia—Prednisone—prostate cancer	0.000175	0.000507	CcSEcCtD
Vorinostat—Headache—Estradiol—prostate cancer	0.000174	0.000504	CcSEcCtD
Vorinostat—Angioedema—Prednisone—prostate cancer	0.000173	0.000501	CcSEcCtD
Vorinostat—Infection—Capecitabine—prostate cancer	0.000172	0.000499	CcSEcCtD
Vorinostat—Anorexia—Docetaxel—prostate cancer	0.00017	0.000494	CcSEcCtD
Vorinostat—Shock—Capecitabine—prostate cancer	0.00017	0.000494	CcSEcCtD
Vorinostat—Body temperature increased—Etoposide—prostate cancer	0.00017	0.000493	CcSEcCtD
Vorinostat—Thrombocytopenia—Capecitabine—prostate cancer	0.00017	0.000492	CcSEcCtD
Vorinostat—Syncope—Prednisone—prostate cancer	0.000169	0.000491	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—prostate cancer	0.000167	0.000485	CcSEcCtD
Vorinostat—Loss of consciousness—Prednisone—prostate cancer	0.000166	0.000482	CcSEcCtD
Vorinostat—Anorexia—Capecitabine—prostate cancer	0.000165	0.000479	CcSEcCtD
Vorinostat—Nausea—Estradiol—prostate cancer	0.000165	0.000478	CcSEcCtD
Vorinostat—Vomiting—Mitoxantrone—prostate cancer	0.000164	0.000477	CcSEcCtD
Vorinostat—Headache—Mitoxantrone—prostate cancer	0.000162	0.00047	CcSEcCtD
Vorinostat—Decreased appetite—Docetaxel—prostate cancer	0.000155	0.000451	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—prostate cancer	0.000155	0.000449	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000154	0.000448	CcSEcCtD
Vorinostat—Asthenia—Etoposide—prostate cancer	0.000154	0.000448	CcSEcCtD
Vorinostat—Fatigue—Docetaxel—prostate cancer	0.000154	0.000447	CcSEcCtD
Vorinostat—Nausea—Mitoxantrone—prostate cancer	0.000154	0.000446	CcSEcCtD
Vorinostat—Infection—Prednisone—prostate cancer	0.000153	0.000444	CcSEcCtD
Vorinostat—Constipation—Docetaxel—prostate cancer	0.000153	0.000444	CcSEcCtD
Vorinostat—Chills—Epirubicin—prostate cancer	0.000152	0.000442	CcSEcCtD
Vorinostat—Pruritus—Etoposide—prostate cancer	0.000152	0.000442	CcSEcCtD
Vorinostat—Shock—Prednisone—prostate cancer	0.000152	0.00044	CcSEcCtD
Vorinostat—Decreased appetite—Capecitabine—prostate cancer	0.000151	0.000437	CcSEcCtD
Vorinostat—Alopecia—Epirubicin—prostate cancer	0.00015	0.000435	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000149	0.000434	CcSEcCtD
Vorinostat—Fatigue—Capecitabine—prostate cancer	0.000149	0.000433	CcSEcCtD
Vorinostat—Constipation—Capecitabine—prostate cancer	0.000148	0.000429	CcSEcCtD
Vorinostat—Diarrhoea—Etoposide—prostate cancer	0.000147	0.000427	CcSEcCtD
Vorinostat—Anorexia—Prednisone—prostate cancer	0.000147	0.000426	CcSEcCtD
Vorinostat—Dysgeusia—Epirubicin—prostate cancer	0.000145	0.00042	CcSEcCtD
Vorinostat—Dizziness—Etoposide—prostate cancer	0.000142	0.000413	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—prostate cancer	0.000142	0.000412	CcSEcCtD
Vorinostat—Body temperature increased—Docetaxel—prostate cancer	0.000141	0.00041	CcSEcCtD
Vorinostat—Chills—Doxorubicin—prostate cancer	0.000141	0.000409	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—prostate cancer	0.000139	0.000403	CcSEcCtD
Vorinostat—Body temperature increased—Capecitabine—prostate cancer	0.000137	0.000397	CcSEcCtD
Vorinostat—Vomiting—Etoposide—prostate cancer	0.000137	0.000397	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—prostate cancer	0.000137	0.000396	CcSEcCtD
Vorinostat—Headache—Etoposide—prostate cancer	0.000135	0.000391	CcSEcCtD
Vorinostat—Decreased appetite—Prednisone—prostate cancer	0.000134	0.000389	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—prostate cancer	0.000134	0.000388	CcSEcCtD
Vorinostat—Fatigue—Prednisone—prostate cancer	0.000133	0.000386	CcSEcCtD
Vorinostat—Syncope—Epirubicin—prostate cancer	0.000133	0.000384	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—prostate cancer	0.000132	0.000384	CcSEcCtD
Vorinostat—Constipation—Prednisone—prostate cancer	0.000132	0.000383	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—prostate cancer	0.000131	0.000381	CcSEcCtD
Vorinostat—Loss of consciousness—Epirubicin—prostate cancer	0.00013	0.000377	CcSEcCtD
Vorinostat—Cough—Epirubicin—prostate cancer	0.000129	0.000374	CcSEcCtD
Vorinostat—Asthenia—Docetaxel—prostate cancer	0.000128	0.000372	CcSEcCtD
Vorinostat—Nausea—Etoposide—prostate cancer	0.000128	0.000371	CcSEcCtD
Vorinostat—Pruritus—Docetaxel—prostate cancer	0.000127	0.000367	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—prostate cancer	0.000126	0.000367	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—prostate cancer	0.000126	0.000365	CcSEcCtD
Vorinostat—Asthenia—Capecitabine—prostate cancer	0.000124	0.00036	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—prostate cancer	0.000123	0.000357	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—prostate cancer	0.000123	0.000356	CcSEcCtD
Vorinostat—Pruritus—Capecitabine—prostate cancer	0.000123	0.000355	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—prostate cancer	0.000122	0.000355	CcSEcCtD
Vorinostat—Diarrhoea—Docetaxel—prostate cancer	0.000122	0.000355	CcSEcCtD
Vorinostat—Body temperature increased—Prednisone—prostate cancer	0.000122	0.000354	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—prostate cancer	0.00012	0.000349	CcSEcCtD
Vorinostat—Infection—Epirubicin—prostate cancer	0.00012	0.000348	CcSEcCtD
Vorinostat—Cough—Doxorubicin—prostate cancer	0.000119	0.000346	CcSEcCtD
Vorinostat—Shock—Epirubicin—prostate cancer	0.000119	0.000344	CcSEcCtD
Vorinostat—Diarrhoea—Capecitabine—prostate cancer	0.000118	0.000344	CcSEcCtD
Vorinostat—Dizziness—Docetaxel—prostate cancer	0.000118	0.000343	CcSEcCtD
Vorinostat—Thrombocytopenia—Epirubicin—prostate cancer	0.000118	0.000343	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—prostate cancer	0.000116	0.000338	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—prostate cancer	0.000115	0.000333	CcSEcCtD
Vorinostat—Dizziness—Capecitabine—prostate cancer	0.000115	0.000332	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—prostate cancer	0.000114	0.00033	CcSEcCtD
Vorinostat—Vomiting—Docetaxel—prostate cancer	0.000114	0.00033	CcSEcCtD
Vorinostat—Headache—Docetaxel—prostate cancer	0.000112	0.000325	CcSEcCtD
Vorinostat—Infection—Doxorubicin—prostate cancer	0.000111	0.000322	CcSEcCtD
Vorinostat—Asthenia—Prednisone—prostate cancer	0.000111	0.000321	CcSEcCtD
Vorinostat—Vomiting—Capecitabine—prostate cancer	0.00011	0.000319	CcSEcCtD
Vorinostat—Shock—Doxorubicin—prostate cancer	0.00011	0.000318	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—prostate cancer	0.000109	0.000317	CcSEcCtD
Vorinostat—Pruritus—Prednisone—prostate cancer	0.000109	0.000316	CcSEcCtD
Vorinostat—Headache—Capecitabine—prostate cancer	0.000108	0.000315	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—prostate cancer	0.000106	0.000309	CcSEcCtD
Vorinostat—Nausea—Docetaxel—prostate cancer	0.000106	0.000308	CcSEcCtD
Vorinostat—Diarrhoea—Prednisone—prostate cancer	0.000106	0.000306	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—prostate cancer	0.000105	0.000304	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000104	0.000302	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—prostate cancer	0.000104	0.000302	CcSEcCtD
Vorinostat—Constipation—Epirubicin—prostate cancer	0.000103	0.000299	CcSEcCtD
Vorinostat—Nausea—Capecitabine—prostate cancer	0.000103	0.000298	CcSEcCtD
Vorinostat—Dizziness—Prednisone—prostate cancer	0.000102	0.000296	CcSEcCtD
Vorinostat—Vomiting—Prednisone—prostate cancer	9.81e-05	0.000284	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—prostate cancer	9.7e-05	0.000281	CcSEcCtD
Vorinostat—Headache—Prednisone—prostate cancer	9.66e-05	0.00028	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.64e-05	0.000279	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—prostate cancer	9.62e-05	0.000279	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—prostate cancer	9.55e-05	0.000277	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—prostate cancer	9.54e-05	0.000277	CcSEcCtD
Vorinostat—Nausea—Prednisone—prostate cancer	9.16e-05	0.000266	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—prostate cancer	8.82e-05	0.000256	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—prostate cancer	8.66e-05	0.000251	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—prostate cancer	8.53e-05	0.000248	CcSEcCtD
Vorinostat—Diarrhoea—Epirubicin—prostate cancer	8.25e-05	0.000239	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—prostate cancer	8.01e-05	0.000232	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—prostate cancer	7.98e-05	0.000231	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—prostate cancer	7.9e-05	0.000229	CcSEcCtD
Vorinostat—Vomiting—Epirubicin—prostate cancer	7.67e-05	0.000222	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—prostate cancer	7.64e-05	0.000221	CcSEcCtD
Vorinostat—Headache—Epirubicin—prostate cancer	7.56e-05	0.000219	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—prostate cancer	7.38e-05	0.000214	CcSEcCtD
Vorinostat—Nausea—Epirubicin—prostate cancer	7.17e-05	0.000208	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—prostate cancer	7.1e-05	0.000206	CcSEcCtD
Vorinostat—Headache—Doxorubicin—prostate cancer	6.99e-05	0.000203	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—prostate cancer	6.63e-05	0.000192	CcSEcCtD
Vorinostat—HDAC3—Signaling Pathways—CXCL8—prostate cancer	7.72e-06	1.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ADRB2—prostate cancer	7.72e-06	1.72e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SRC—prostate cancer	7.66e-06	1.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTEN—prostate cancer	7.63e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—prostate cancer	7.62e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—prostate cancer	7.61e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—prostate cancer	7.6e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—prostate cancer	7.59e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MDM2—prostate cancer	7.59e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—prostate cancer	7.57e-06	1.69e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TGFB1—prostate cancer	7.55e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1B—prostate cancer	7.54e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—GSK3B—prostate cancer	7.54e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VAV3—prostate cancer	7.53e-06	1.68e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—prostate cancer	7.48e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—prostate cancer	7.46e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—BAD—prostate cancer	7.46e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1A—prostate cancer	7.44e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—prostate cancer	7.44e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—INS—prostate cancer	7.44e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTEN—prostate cancer	7.43e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TGFB1—prostate cancer	7.42e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFBR2—prostate cancer	7.42e-06	1.66e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—prostate cancer	7.41e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—prostate cancer	7.39e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CASP3—prostate cancer	7.39e-06	1.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CB—prostate cancer	7.38e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—prostate cancer	7.38e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—prostate cancer	7.38e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—prostate cancer	7.37e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EP300—prostate cancer	7.37e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—AKT1—prostate cancer	7.37e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ITPR1—prostate cancer	7.3e-06	1.63e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CREBBP—prostate cancer	7.28e-06	1.63e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—prostate cancer	7.28e-06	1.63e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—EP300—prostate cancer	7.28e-06	1.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APC—prostate cancer	7.23e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—CREBBP—prostate cancer	7.22e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—prostate cancer	7.19e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF1—prostate cancer	7.19e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SRC—prostate cancer	7.17e-06	1.6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGF—prostate cancer	7.14e-06	1.6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IRS1—prostate cancer	7.14e-06	1.6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—prostate cancer	7.12e-06	1.59e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—prostate cancer	7.09e-06	1.58e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EP300—prostate cancer	7.08e-06	1.58e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—prostate cancer	7e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—prostate cancer	6.99e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—prostate cancer	6.98e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—prostate cancer	6.98e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—prostate cancer	6.98e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1R—prostate cancer	6.98e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—prostate cancer	6.97e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1A—prostate cancer	6.96e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAP2K1—prostate cancer	6.95e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTEN—prostate cancer	6.94e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—GSK3B—prostate cancer	6.94e-06	1.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1B—prostate cancer	6.93e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—prostate cancer	6.91e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CD—prostate cancer	6.9e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—prostate cancer	6.89e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SRC—prostate cancer	6.89e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—prostate cancer	6.88e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—prostate cancer	6.87e-06	1.53e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TGFB1—prostate cancer	6.85e-06	1.53e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—INS—prostate cancer	6.84e-06	1.53e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SERPINE1—prostate cancer	6.83e-06	1.53e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—AKT1—prostate cancer	6.81e-06	1.52e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—AKT1—prostate cancer	6.8e-06	1.52e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CASP3—prostate cancer	6.79e-06	1.52e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—prostate cancer	6.78e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SERPINE1—prostate cancer	6.77e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—prostate cancer	6.76e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—prostate cancer	6.75e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—prostate cancer	6.72e-06	1.5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CREBBP—prostate cancer	6.7e-06	1.5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—LPL—prostate cancer	6.69e-06	1.49e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—AKT1—prostate cancer	6.65e-06	1.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—prostate cancer	6.65e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—prostate cancer	6.64e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDGFRB—prostate cancer	6.63e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EP300—prostate cancer	6.62e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FGF2—prostate cancer	6.61e-06	1.48e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—prostate cancer	6.61e-06	1.48e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—prostate cancer	6.55e-06	1.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOS3—prostate cancer	6.52e-06	1.46e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ITGB3—prostate cancer	6.46e-06	1.44e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SRC—prostate cancer	6.44e-06	1.44e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—prostate cancer	6.43e-06	1.44e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—prostate cancer	6.42e-06	1.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—prostate cancer	6.42e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TGFB1—prostate cancer	6.41e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAP2K1—prostate cancer	6.4e-06	1.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1A—prostate cancer	6.39e-06	1.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTEN—prostate cancer	6.38e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—AKT1—prostate cancer	6.36e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CD—prostate cancer	6.35e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—prostate cancer	6.34e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—JAK2—prostate cancer	6.34e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—prostate cancer	6.32e-06	1.41e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SERPINE1—prostate cancer	6.28e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—prostate cancer	6.28e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—prostate cancer	6.27e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB3—prostate cancer	6.27e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGFR2—prostate cancer	6.26e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—prostate cancer	6.21e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—prostate cancer	6.19e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MDM2—prostate cancer	6.19e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—prostate cancer	6.18e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—prostate cancer	6.17e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TGFB1—prostate cancer	6.16e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—prostate cancer	6.11e-06	1.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—prostate cancer	6.1e-06	1.36e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EP300—prostate cancer	6.08e-06	1.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FGF2—prostate cancer	6.08e-06	1.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—prostate cancer	6.04e-06	1.35e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CB—prostate cancer	6.02e-06	1.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TERT—prostate cancer	6.01e-06	1.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS3—prostate cancer	6e-06	1.34e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—prostate cancer	5.93e-06	1.33e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SRC—prostate cancer	5.92e-06	1.32e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—prostate cancer	5.86e-06	1.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—JAK2—prostate cancer	5.83e-06	1.3e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—prostate cancer	5.83e-06	1.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—prostate cancer	5.78e-06	1.29e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—prostate cancer	5.77e-06	1.29e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—prostate cancer	5.76e-06	1.29e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TGFB1—prostate cancer	5.76e-06	1.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—prostate cancer	5.75e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—AKT1—prostate cancer	5.71e-06	1.28e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—prostate cancer	5.71e-06	1.27e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—AKT1—prostate cancer	5.71e-06	1.27e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—prostate cancer	5.7e-06	1.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—AKT1—prostate cancer	5.7e-06	1.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MDM2—prostate cancer	5.69e-06	1.27e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—prostate cancer	5.69e-06	1.27e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—AKT1—prostate cancer	5.65e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1B—prostate cancer	5.65e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—prostate cancer	5.64e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—prostate cancer	5.64e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—prostate cancer	5.61e-06	1.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—LEP—prostate cancer	5.61e-06	1.25e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—prostate cancer	5.59e-06	1.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CAV1—prostate cancer	5.56e-06	1.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CB—prostate cancer	5.54e-06	1.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CASP3—prostate cancer	5.54e-06	1.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—prostate cancer	5.53e-06	1.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—prostate cancer	5.49e-06	1.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—prostate cancer	5.49e-06	1.23e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—prostate cancer	5.45e-06	1.22e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—prostate cancer	5.39e-06	1.2e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—prostate cancer	5.38e-06	1.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ESR1—prostate cancer	5.35e-06	1.2e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—prostate cancer	5.34e-06	1.19e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—prostate cancer	5.33e-06	1.19e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—prostate cancer	5.3e-06	1.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TGFB1—prostate cancer	5.29e-06	1.18e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—prostate cancer	5.27e-06	1.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—AKT1—prostate cancer	5.25e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—prostate cancer	5.24e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—prostate cancer	5.23e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—BAD—prostate cancer	5.23e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1A—prostate cancer	5.21e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTEN—prostate cancer	5.2e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1B—prostate cancer	5.2e-06	1.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—prostate cancer	5.19e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—prostate cancer	5.16e-06	1.15e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—AKT1—prostate cancer	5.16e-06	1.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CG—prostate cancer	5.06e-06	1.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APC—prostate cancer	5.06e-06	1.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IRS1—prostate cancer	5e-06	1.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGF—prostate cancer	5e-06	1.12e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EP300—prostate cancer	4.96e-06	1.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—prostate cancer	4.91e-06	1.1e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—prostate cancer	4.9e-06	1.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—prostate cancer	4.9e-06	1.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GSK3B—prostate cancer	4.86e-06	1.08e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—prostate cancer	4.83e-06	1.08e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SRC—prostate cancer	4.82e-06	1.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1A—prostate cancer	4.8e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—INS—prostate cancer	4.79e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTEN—prostate cancer	4.79e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—AKT1—prostate cancer	4.78e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—AKT1—prostate cancer	4.76e-06	1.06e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—prostate cancer	4.74e-06	1.06e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—prostate cancer	4.7e-06	1.05e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CREBBP—prostate cancer	4.69e-06	1.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—prostate cancer	4.65e-06	1.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—prostate cancer	4.64e-06	1.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1—prostate cancer	4.63e-06	1.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—AKT1—prostate cancer	4.61e-06	1.03e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EP300—prostate cancer	4.56e-06	1.02e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—prostate cancer	4.5e-06	1.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAP2K1—prostate cancer	4.48e-06	1e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—AKT1—prostate cancer	4.45e-06	9.95e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CD—prostate cancer	4.45e-06	9.94e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SRC—prostate cancer	4.44e-06	9.91e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SERPINE1—prostate cancer	4.4e-06	9.83e-06	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—AKT1—prostate cancer	4.4e-06	9.82e-06	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—prostate cancer	4.35e-06	9.73e-06	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—prostate cancer	4.34e-06	9.69e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—prostate cancer	4.32e-06	9.65e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TGFB1—prostate cancer	4.31e-06	9.63e-06	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—prostate cancer	4.28e-06	9.57e-06	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT1—prostate cancer	4.28e-06	9.56e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—prostate cancer	4.28e-06	9.56e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGF2—prostate cancer	4.26e-06	9.52e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—prostate cancer	4.23e-06	9.44e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOS3—prostate cancer	4.2e-06	9.39e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JAK2—prostate cancer	4.08e-06	9.12e-06	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT1—prostate cancer	4e-06	8.94e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—prostate cancer	3.99e-06	8.92e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MDM2—prostate cancer	3.99e-06	8.9e-06	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—prostate cancer	3.99e-06	8.9e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—prostate cancer	3.98e-06	8.88e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TGFB1—prostate cancer	3.97e-06	8.86e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—prostate cancer	3.93e-06	8.78e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—prostate cancer	3.89e-06	8.69e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CB—prostate cancer	3.88e-06	8.66e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—prostate cancer	3.73e-06	8.33e-06	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT1—prostate cancer	3.68e-06	8.21e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—prostate cancer	3.67e-06	8.21e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—prostate cancer	3.67e-06	8.2e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1B—prostate cancer	3.64e-06	8.13e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CASP3—prostate cancer	3.57e-06	7.97e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—prostate cancer	3.56e-06	7.96e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—prostate cancer	3.55e-06	7.93e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—prostate cancer	3.47e-06	7.76e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—prostate cancer	3.44e-06	7.68e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—prostate cancer	3.38e-06	7.54e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—prostate cancer	3.37e-06	7.53e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1A—prostate cancer	3.36e-06	7.5e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTEN—prostate cancer	3.35e-06	7.49e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—prostate cancer	3.25e-06	7.26e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EP300—prostate cancer	3.2e-06	7.14e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SRC—prostate cancer	3.11e-06	6.94e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—prostate cancer	3.03e-06	6.76e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—prostate cancer	3e-06	6.7e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT1—prostate cancer	3e-06	6.7e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—prostate cancer	2.99e-06	6.68e-06	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—AKT1—prostate cancer	2.97e-06	6.64e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—prostate cancer	2.79e-06	6.22e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFB1—prostate cancer	2.78e-06	6.21e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT1—prostate cancer	2.76e-06	6.16e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—prostate cancer	2.72e-06	6.09e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—prostate cancer	2.57e-06	5.75e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—prostate cancer	2.36e-06	5.28e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—prostate cancer	2.29e-06	5.11e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—prostate cancer	2.09e-06	4.68e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT1—prostate cancer	1.93e-06	4.31e-06	CbGpPWpGaD
